AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Rafael Depetris
Lead of Structure Based Drug Design at Kadmon Corporation, LLC, USA

Profile

Rafael obtained his Ph.D. from NYU in 2008 working with Stevan Hubbard in the field of X-Ray crystallography, specifically focusing on the structural analysis of proteins that interact with the insulin receptor. His post-graduate work was done at Weill Cornell Medical College where he focused in the structural analysis of the HIV-1 Envelope proteins as well as of the HIV-1 neutralizing antibodies. Rafael went on to assume a position of a Senior Scientist at Pfizer CTI in New York, where he initiated his work focused on modeling of targets and therapeutic antibody candidates. He was also commanding the efforts for the humanization of the lead antibody candidates based on the modeling analyses. Rafael is continuing to explore structural features of biologics and their targets in his current position as a Principal Scientist at the Kadmon Corporation in NYC. At Kadmon he is combining his expertise in structural biology with in silico approaches to drive forward discovery projects. He has participated in many symposia, speaking about the interplay of structural analysis and computational tools.

Rafael Depetris's Network

Agenda Sessions

  • Chairperson's Opening and Welcome

    , 8:10am

Speakers at this event